Cannabis investors will soon see a Canadian pot stock join the New York Stock Exchange.

Aurora Cannabis (TSX:ACB) announced on Thursday (October 18) it obtained confirmation of approval to list its shares on the New York Stock Exchange (NYSE) starting on October 23.


The approval from the NYSE for Aurora’s listing was issued on Wednesday (October 17).

Aurora had previously confirmed it would use the same ticker symbol, ACB, for its US-listed shares.

The company already has a US listing through the OTCQX, but will delist from that exchange once its NYSE stock launches.

Terry Booth, CEO of Aurora, said the listing is indicative of the domestic and international growth initiatives from the company, including expanding its “base of global institutional and retail investors.”

Canadian cannabis companies transition stock into the US

Aurora’s move continues the trend of Canadian cannabis companies seeking higher class US listings as a way to attract a wider investor audience.

Cronos Group (NASDAQ:CRON,TSX:CRON) was the first to uplist in February, followed by Canopy Growth (NYSE:CGC,TSX:WEED) in May.

Tilray (NASDAQ:TLRY) became the first Canadian LP to directly launch its initial public offering (IPO) on the NASDAQ in July.

“We believe this will increase long-term shareholder value by improving awareness, liquidity, and appeal to institutional investors,” Mike Gorenstein CEO of Cronos said at the time of the company’s announcement.

Investor takeaway

Shares of Aurora rose on Thursday, following a dip on the same day as recreational legalization in Canada. The company closed the trading session with a 1.40 percent increase to price per share of C$13.76.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less